Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

IRF-7 is the master regulator of type-I interferon-dependent immune responses.

Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T.

Nature. 2005 Apr 7;434(7034):772-7. Epub 2005 Mar 30.

PMID:
15800576
[PubMed - indexed for MEDLINE]
Free Article
2.

The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation.

Giménez-Barcons M, Wang C, Chen M, Sánchez-Tapias JM, Sáiz JC, Gale M Jr.

J Interferon Cytokine Res. 2005 Mar;25(3):152-64.

PMID:
15767789
[PubMed - indexed for MEDLINE]
3.

Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease.

Ferreon JC, Ferreon AC, Li K, Lemon SM.

J Biol Chem. 2005 May 27;280(21):20483-92. Epub 2005 Mar 14.

PMID:
15767257
[PubMed - indexed for MEDLINE]
Free Article
4.

Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Li K, Chen Z, Kato N, Gale M Jr, Lemon SM.

J Biol Chem. 2005 Apr 29;280(17):16739-47. Epub 2005 Feb 28.

PMID:
15737993
[PubMed - indexed for MEDLINE]
Free Article
5.

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

Schulz O, Diebold SS, Chen M, Näslund TI, Nolte MA, Alexopoulou L, Azuma YT, Flavell RA, Liljeström P, Reis e Sousa C.

Nature. 2005 Feb 24;433(7028):887-92. Epub 2005 Feb 13.

PMID:
15711573
[PubMed - indexed for MEDLINE]
Free Article
6.

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Foy E, Li K, Sumpter R Jr, Loo YM, Johnson CL, Wang C, Fish PM, Yoneyama M, Fujita T, Lemon SM, Gale M Jr.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2986-91. Epub 2005 Feb 14.

PMID:
15710892
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr, Lemon SM.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2992-7. Epub 2005 Feb 14.

PMID:
15710891
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M Jr.

J Virol. 2005 Mar;79(5):2689-99.

PMID:
15708988
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites.

Han JQ, Wroblewski G, Xu Z, Silverman RH, Barton DJ.

J Interferon Cytokine Res. 2004 Nov;24(11):664-76.

PMID:
15684820
[PubMed - indexed for MEDLINE]
11.

Uptake and presentation of hepatitis C virus-like particles by human dendritic cells.

Barth H, Ulsenheimer A, Pape GR, Diepolder HM, Hoffmann M, Neumann-Haefelin C, Thimme R, Henneke P, Klein R, Paranhos-Baccalà G, Depla E, Liang TJ, Blum HE, Baumert TF.

Blood. 2005 May 1;105(9):3605-14. Epub 2005 Jan 18.

PMID:
15657184
[PubMed - indexed for MEDLINE]
Free Article
12.

Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication.

Waris G, Turkson J, Hassanein T, Siddiqui A.

J Virol. 2005 Feb;79(3):1569-80.

PMID:
15650183
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Plasmacytoid dendritic cells in immunity.

Colonna M, Trinchieri G, Liu YJ.

Nat Immunol. 2004 Dec;5(12):1219-26. Review.

PMID:
15549123
[PubMed - indexed for MEDLINE]
14.

Pathogenesis of hepatitis C-associated hepatocellular carcinoma.

Liang TJ, Heller T.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S62-71. Review.

PMID:
15508105
[PubMed - indexed for MEDLINE]
15.

Cell-mediated immunity and the outcome of hepatitis C virus infection.

Shoukry NH, Cawthon AG, Walker CM.

Annu Rev Microbiol. 2004;58:391-424. Review.

PMID:
15487943
[PubMed - indexed for MEDLINE]
16.

Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model.

Sumpter R Jr, Wang C, Foy E, Loo YM, Gale M Jr.

J Virol. 2004 Nov;78(21):11591-604.

PMID:
15479800
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Toll-like receptor control of the adaptive immune responses.

Iwasaki A, Medzhitov R.

Nat Immunol. 2004 Oct;5(10):987-95. Review.

PMID:
15454922
[PubMed - indexed for MEDLINE]
18.

Toll-like receptors in the pathogenesis of human disease.

Cook DN, Pisetsky DS, Schwartz DA.

Nat Immunol. 2004 Oct;5(10):975-9. Review.

PMID:
15454920
[PubMed - indexed for MEDLINE]
19.

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.

Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue J, Uematsu S, Takeuchi O, Akira S.

Nat Immunol. 2004 Oct;5(10):1061-8. Epub 2004 Sep 7.

PMID:
15361868
[PubMed - indexed for MEDLINE]
20.

Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, Yamashiro T, Tanabe Y, Maekawa S, Nakagawa M, Chen CH, Kakinuma S, Oshima S, Nakamura T, Kato T, Wakita T, Watanabe M.

J Virol. 2004 Sep;78(18):9713-20.

PMID:
15331704
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk